The earnings call presented a mixed picture with some positive developments in international growth and gross margin improvement, but ongoing challenges in U.S. growth, rising expenses, persistent net loss, and decreasing cash reserves. The focus on execution and profitability suggests attempts to address these issues, but immediate growth strategies remain uncertain.
Company Guidance
During the Pulmonx conference call, the company provided guidance for the fiscal year 2025, projecting full-year revenue between $89 million and $90 million. They anticipate a gross margin of approximately 73% and expect operating expenses to range from $125 million to $126 million, which includes about $21 million in noncash stock-based compensation. The company reported a total worldwide revenue of $21.5 million for Q3 2025, marking a 5% increase from the previous year. U.S. revenue saw a 1% rise to $14 million, while international revenue grew by 15% to $7.5 million. Gross margin for the quarter increased slightly to 75%. Pulmonx ended the quarter with $76.5 million in cash and cash equivalents, a decrease of $7.7 million from the second quarter, and noted a total cash utilization of approximately $25 million for the first three quarters of 2025. They highlighted a strategic focus on extending their cash runway and improving operating leverage by reallocating resources to high-return areas.
Revenue Growth
Total worldwide revenue for the quarter ended September 30, 2025, was $21.5 million, a 5% increase from $20.4 million in the same period of the prior year.
International Revenue Surge
International revenue for the third quarter of 2025 was $7.5 million, a 15% increase compared to $6.6 million in the same period last year.
Gross Margin Improvement
Gross margin for the third quarter of 2025 was approximately 75%, up from 74% in the same period last year.
Pulmonx (LUNG) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LUNG Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2025
$1.96
$1.59
-18.88%
Jul 30, 2025
$3.15
$1.84
-41.59%
Apr 30, 2025
$4.83
$3.77
-21.95%
Feb 19, 2025
$6.64
$8.78
+32.23%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Pulmonx (LUNG) report earnings?
Pulmonx (LUNG) is schdueled to report earning on Feb 25, 2026, After Close (Confirmed).
What is Pulmonx (LUNG) earnings time?
Pulmonx (LUNG) earnings time is at Feb 25, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.